Effectiveness of human atrial natriuretic peptide supplementation in pulmonary edema patients using the pulse contour cardiac output system

Yonsei Medical Journal

Volumn 51, Issue 3, 2010, Pages 354-359

  Sakamoto, Yuichiro ^a   Mashiko, Kunihiro ^a   Saito, Nobuyuki ^a   Matsumoto, Hisashi ^a   Hara, Yoshiaki ^a   Kutsukata, Noriyoshi ^a   Yokota, Hiroyuki ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

Human atrial natriuretic peptide (HANP); Pulmonary edema; Pulse contour cardiac output (PiCCO)

Indexed keywords

ATRIAL NATRIURETIC FACTOR ALPHA;

ADULT; AGED; ARTICLE; BLOOD VESSEL PERMEABILITY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HORMONAL THERAPY; HUMAN; LUNG BLOOD VOLUME; LUNG EDEMA; LUNG EXTRAVASCULAR FLUID; MALE; MONITOR; PULSE CONTOUR CADIAC OUTPUT SYSTEM; THORAX RADIOGRAPHY; TREATMENT OUTCOME;

AGED; ATRIAL NATRIURETIC FACTOR; CARDIAC OUTPUT; FEMALE; HUMANS; INJECTIONS, INTRAVENOUS; MALE; MIDDLE AGED; MONITORING, PHYSIOLOGIC; PULMONARY EDEMA;

EID: 77954303019     PISSN: 05135796     EISSN: None     Source Type: Journal    
DOI: 10.3349/ymj.2010.51.3.354     Document Type: Article

References (12)

1. Needleman P, Greenwald JE. Atriopeptin: a cardiac hormone intimately involved in fluid, electrolyte, and blood-pressure homeostasis. N Engl J Med 1986;314:828-34.
2. Tanabe M, Ueda M, Endo M, Kitajima M. Effect of acute lung injury and coexisting disorders on plasma concentrations of atrial natriuretic peptide. Crit Care Med 1994;22:1762-8.
3. Langman CB, Engle WD, Baumgart S, Fox WW, Polin RA. The diuretic phase of respiratory distress syndrome and its relationship to oxygenation. J Pediatr 1981;98:462-6.
4. Heaf DP, Belik J, Spitzer AR, Gewitz MH, Fox WW. Changes in pulmonary function during the diuretic phase of respiratory distress syndrome. J Pediatr 1982;101:103-7.
5. Tanabe M, Ueda M, Endo M, Kitajima M. The effect of atrial natriuretic peptide on pulmonary acid injury in a pig model. Am J Respir Crit Care Med 1996;154:1351-6.
6. Mitaka C, Hirata Y, Nagura T, Tsunoda Y, Amaha K. Beneficial effect of atrial natriuretic peptide on pulmonary gas exchange in patients with acute lung injury. Chest 1998;114:223-8.
7. Sumi K, Iida H, Yamaguchi S, Fukuoka N, Shimabukuro K, Dohi S. Human atrial natriuretic peptide prevents the increase in pulmonary artery pressure associated with aortic unclamping during abdominal aortic aneurysmectomy. J Cardiothorac Vasc Anesth 2008;22:204-9.
8. Berkowitz DM, Danai PA, Eaton S, Moss M, Martin GS. Accurate characterization of extravascular lung water in acute respiratory distress syndrome. Crit Care Med 2008;36:1803-9.
9. Imamura T, Ohnuma N, Iwasa F, Furuya M, Hayashi Y, Inomata N, et al. Prorective effect of aipha-human atrial natriuretic polypeptide (alpha-hANP) on chemical induced pulmonary edema. Life Sci 1988;42:403-14.
10. Baron DA, Lofton CE, Newman WH, Currie MG. Atriopeptin inhibition of thrombin-mediated changes in the morphology and permeability of endothelial monolayers. Proc Natl Acad Sci U S A 1989;86:3394-8.
11. Lofton CE, Baron DA, Heffner JE, Currie MG, Newman WH. Atrial natriuretic peptide inhibits oxidant-induced increases in endothelial permeability. J Mol Cell Cardiol 1991;23:919-27.
12. Michard F. Bedside assessment of extravascular lung water by dilution methods: temptations and pitfalls. Crit Care Med 2007; 35:1186-92.